Protagonist Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 30.882 million compared to USD 18.217 million a year ago. Net loss was USD 30.842 million compared to USD 19.421 million a year ago. Basic loss per share from continuing operations was USD 0.69 compared to USD 0.59 a year ago. For the half year, operating loss was USD 54.903 million compared to USD 37.914 million a year ago. Net loss was USD 54.840 million compared to USD 39.501 million a year ago. Basic loss per share from continuing operations was USD 1.23 compared to USD 1.31 a year ago.